Literature DB >> 10998507

Poloxamers and poloxamines in nanoparticle engineering and experimental medicine.

S M Moghimi1, A C Hunter.   

Abstract

Poloxamers and poloxamine nonionic surfactants have diverse applications in various biomedical fields ranging from drug delivery and medical imaging to management of vascular diseases and disorders. Although this is a progressive, rapidly advancing field in biotechnology, the future will depend on the recognition and rectification of a range of toxicity issues, which have to be addressed but have frequently been ignored until now.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10998507     DOI： 10.1016/s0167-7799(00)01485-2

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN： 0167-7799            Impact factor:   19.536


  42 in total

1.  Effect of PEG surface conformation on anticancer activity and blood circulation of nanoemulsions loaded with tocotrienol-rich fraction of palm oil.

Authors:  Alaadin Alayoubi; Saeed Alqahtani; Amal Kaddoumi; Sami Nazzal
Journal:  AAPS J       Date:  2013-08-30       Impact factor: 4.009

Review 2.  A review of poloxamer 407 pharmaceutical and pharmacological characteristics.

Authors:  Gilles Dumortier; Jean Louis Grossiord; Florence Agnely; Jean Claude Chaumeil
Journal:  Pharm Res       Date:  2006-11-11       Impact factor: 4.200

3.  Delivery of water-soluble drugs using acoustically triggered perfluorocarbon double emulsions.

Authors:  Mario L Fabiilli; James A Lee; Oliver D Kripfgans; Paul L Carson; J Brian Fowlkes
Journal:  Pharm Res       Date:  2010-09-25       Impact factor: 4.200

4.  Safety, heart specificity, and therapeutic effect evaluation of Guanfu base A-loaded solid nanolipids in treating arrhythmia.

Authors:  Fei Xiong; Kunliang Liu; Sha Liu; Jianjun Chen; Jinghan Liu; Hao Wang; Ning Gu
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

5.  Interaction studies between indomethacin nanocrystals and PEO/PPO copolymer stabilizers.

Authors:  Peng Liu; Tapani Viitala; Alma Kartal-Hodzic; Huamin Liang; Timo Laaksonen; Jouni Hirvonen; Leena Peltonen
Journal:  Pharm Res       Date:  2014-08-22       Impact factor: 4.200

Review 6.  Systemic delivery to central nervous system by engineered PLGA nanoparticles.

Authors:  Qiang Cai; Long Wang; Gang Deng; Junhui Liu; Qianxue Chen; Zhibiao Chen
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

7.  Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer.

Authors:  David Powell; Sruti Chandra; Kyra Dodson; Farhana Shaheen; Kylar Wiltz; Shubha Ireland; Muniruzzaman Syed; Srikanta Dash; Thomas Wiese; Tarun Mandal; Anup Kundu
Journal:  Eur J Pharm Biopharm       Date:  2017-01-25       Impact factor: 5.571

8.  Formulations for trans-tympanic antibiotic delivery.

Authors:  Xiaojuan Khoo; Emmanuel J Simons; Homer H Chiang; Julia M Hickey; Vishakha Sabharwal; Stephen I Pelton; John J Rosowski; Robert Langer; Daniel S Kohane
Journal:  Biomaterials       Date:  2012-11-09       Impact factor: 12.479

Review 9.  Factors affecting the clearance and biodistribution of polymeric nanoparticles.

Authors:  Frank Alexis; Eric Pridgen; Linda K Molnar; Omid C Farokhzad
Journal:  Mol Pharm       Date:  2008-08-04       Impact factor: 4.939

10.  A Novel Docetaxel-Loaded Poly (ε-Caprolactone)/Pluronic F68 Nanoparticle Overcoming Multidrug Resistance for Breast Cancer Treatment.

Authors:  Lin Mei; Yangqing Zhang; Yi Zheng; Ge Tian; Cunxian Song; Dongye Yang; Hongli Chen; Hongfan Sun; Yan Tian; Kexin Liu; Zhen Li; Laiqiang Huang
Journal:  Nanoscale Res Lett       Date:  2009-09-16       Impact factor: 4.703
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.